Effects of local variation, specialty, and beliefs on antiviral prescribing for influenza

Clinical Infectious Diseases

Volumn 42, Issue 1, 2006, Pages 95-99

  Rothberg, Michael B ^a,b   Bonner, Aleta B ^c,d   Hasan Rajab, M ^c,d   Kim, Hyun Sun ^a,c   Stechenberg, Barbara W ^a   Rose, David N ^a,b  

^a BAYSTATE MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^d TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PRACTICE; INFLUENZA; MEDICAL SPECIALIST; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; UNITED STATES;

ANTIVIRAL AGENTS; CULTURE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFLUENZA, HUMAN; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; SPECIALTIES, MEDICAL; UNITED STATES;

EID: 29244473562     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/498517     Document Type: Article

References (12)

1. Nicholson KG, Wood JM, Zambon M. Influenza. Lancet 2003; 362: 1733-45.
2. Turner D, Wailoo A, Nicholson K, et al. Systematic review and economic decision modelling for the prevention and treatment of influenza A and B. Health Technol Assess 2003; 7:iii-iv, xi-xiii, 1-170.
3. Centers for Disease Control and Prevention. Influenza antiviral medications: 2004-05 interim chemoprophylaxis and treatment guidelines. Centers for Disease Control and Prevention, 2004. Available at: http: //www.cdc.gov/flu/professionals/treatment/0405antiviralguide.htm. Accessed 24 May 2005.
4. Uyeki TM. Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza. Pediatr Infect Dis J 2003; 22:164-77.
5. Bonner AB, Monroe KW, Talley LI, Klasner AE, Kimberlin DW. Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: results of a randomized, prospective, controlled trial. Pediatrics 2003; 112:363-7.
6. Smith KJ, Roberts MS. Cost-effectiveness of newer treatment strategies for influenza. Am J Med 2002; 113:300-7.
7. Rothberg MB, He S, Rose DN. Management of influenza symptoms in healthy adults. J Gen Intern Med 2003; 18:808-15.
8. Centers for Disease Control and Prevention. Update: influenza activity-United States and worldwide, 2003-04 season, and composition of the 2004-05 influenza vaccine. MMWR Morb Mortal Wkly Rep 2004; 53:547-52.
9. Kaiser L, Wat C, Mills T, Mahoney P, Ward P, Hayden F. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med 2003; 163: 1667-72.
10. Lee PY, Matchar DB, Clements DA, Huber J, Hamilton JD, Peterson ED. Economic analysis of influenza vaccination and antiviral treatment for healthy working adults. Ann Intern Med 2002; 137:225-31.
11. Muennig PA, Khan K. Cost-effectiveness of vaccination versus treatment of influenza in healthy adolescents and adults. Clin Infect Dis 2001; 33:1879-85.
12. Rothberg MB, Bellantonio S, Rose DN. Management of influenza in adults older than 65 years of age: cost-effectiveness of rapid testing and antiviral therapy. Ann Intern Med 2003; 139:321-9.